P, M., GL, V., A, N., T, A., A, L., M, F., . . . M, R. (2025). COMBINED INTRAVITREAL AFLIBERCEPT AND ANTI-INFLAMMATORY ORAL SUPPLEMENTATION IN THE TREATMENT OF DIABETIC MACULAR EDEMA: Two-Year Randomized Controlled Trial Results. Retina (Philadelphia, Pa.), 45(6), 1134. https://doi.org/10.1097/IAE.0000000000004427
Chicago Style (17th ed.) CitationP, Marolo, et al. "COMBINED INTRAVITREAL AFLIBERCEPT AND ANTI-INFLAMMATORY ORAL SUPPLEMENTATION IN THE TREATMENT OF DIABETIC MACULAR EDEMA: Two-Year Randomized Controlled Trial Results." Retina (Philadelphia, Pa.) 45, no. 6 (2025): 1134. https://doi.org/10.1097/IAE.0000000000004427.
MLA (9th ed.) CitationP, Marolo, et al. "COMBINED INTRAVITREAL AFLIBERCEPT AND ANTI-INFLAMMATORY ORAL SUPPLEMENTATION IN THE TREATMENT OF DIABETIC MACULAR EDEMA: Two-Year Randomized Controlled Trial Results." Retina (Philadelphia, Pa.), vol. 45, no. 6, 2025, p. 1134, https://doi.org/10.1097/IAE.0000000000004427.